FDA-Approved Drug Repurposing as p53 Mutants Rescue Candidates Using Structure-Based Virtual Screening and Molecular Simulations

Mena Abdelsayed, Yassir Boulaamane

Open source

DOI
10.3390/ijms27156677
Published
2026-07-27
Container
International Journal of Molecular Sciences
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms27156677,
  title = {FDA-Approved Drug Repurposing as p53 Mutants Rescue Candidates Using Structure-Based Virtual Screening and Molecular Simulations},
  author = {Mena Abdelsayed and Yassir Boulaamane},
  year = {2026},
  journal = {International Journal of Molecular Sciences},
  doi = {10.3390/ijms27156677},
  url = {https://doi.org/10.3390/ijms27156677}
}

RIS

TY  - JOUR
TI  - FDA-Approved Drug Repurposing as p53 Mutants Rescue Candidates Using Structure-Based Virtual Screening and Molecular Simulations
AU  - Mena Abdelsayed
AU  - Yassir Boulaamane
PY  - 2026
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27156677
UR  - https://doi.org/10.3390/ijms27156677
ER  - 

APA

Abdelsayed, M., & Boulaamane, Y. (2026). FDA-Approved Drug Repurposing as p53 Mutants Rescue Candidates Using Structure-Based Virtual Screening and Molecular Simulations. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27156677

Source records